IBDEI1NL ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28073,1,3,0)
 ;;=3^TESTOSTERONE ENANTHATE 1MG
 ;;^UTILITY(U,$J,358.3,28074,0)
 ;;=J2357^^111^1399^85^^^^1
 ;;^UTILITY(U,$J,358.3,28074,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28074,1,2,0)
 ;;=2^J2357
 ;;^UTILITY(U,$J,358.3,28074,1,3,0)
 ;;=3^XOLAIR 5MG
 ;;^UTILITY(U,$J,358.3,28075,0)
 ;;=J2505^^111^1399^66^^^^1
 ;;^UTILITY(U,$J,358.3,28075,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28075,1,2,0)
 ;;=2^J2505
 ;;^UTILITY(U,$J,358.3,28075,1,3,0)
 ;;=3^PEGFILGRASTIM 6MG
 ;;^UTILITY(U,$J,358.3,28076,0)
 ;;=J0202^^111^1399^3^^^^1
 ;;^UTILITY(U,$J,358.3,28076,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28076,1,2,0)
 ;;=2^J0202
 ;;^UTILITY(U,$J,358.3,28076,1,3,0)
 ;;=3^ALEMTUZUMAB 1MG
 ;;^UTILITY(U,$J,358.3,28077,0)
 ;;=J0596^^111^1399^12^^^^1
 ;;^UTILITY(U,$J,358.3,28077,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28077,1,2,0)
 ;;=2^J0596
 ;;^UTILITY(U,$J,358.3,28077,1,3,0)
 ;;=3^C1 ESTERASE INHIBITOR 10U
 ;;^UTILITY(U,$J,358.3,28078,0)
 ;;=J0695^^111^1399^15^^^^1
 ;;^UTILITY(U,$J,358.3,28078,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28078,1,2,0)
 ;;=2^J0695
 ;;^UTILITY(U,$J,358.3,28078,1,3,0)
 ;;=3^CEFTOLOZANE 50MG AND TAZOBACTAM 25MG
 ;;^UTILITY(U,$J,358.3,28079,0)
 ;;=J0714^^111^1399^14^^^^1
 ;;^UTILITY(U,$J,358.3,28079,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28079,1,2,0)
 ;;=2^J0714
 ;;^UTILITY(U,$J,358.3,28079,1,3,0)
 ;;=3^CEFTAZIDIME AND AVIBACTAM 0.5G/0.125G
 ;;^UTILITY(U,$J,358.3,28080,0)
 ;;=J0875^^111^1399^18^^^^1
 ;;^UTILITY(U,$J,358.3,28080,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28080,1,2,0)
 ;;=2^J0875
 ;;^UTILITY(U,$J,358.3,28080,1,3,0)
 ;;=3^DALBAVANCIN 5MG
 ;;^UTILITY(U,$J,358.3,28081,0)
 ;;=J1443^^111^1399^26^^^^1
 ;;^UTILITY(U,$J,358.3,28081,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28081,1,2,0)
 ;;=2^J1443
 ;;^UTILITY(U,$J,358.3,28081,1,3,0)
 ;;=3^FERRIC PYROPHOSPHATE CITRIC SOL .01MG
 ;;^UTILITY(U,$J,358.3,28082,0)
 ;;=J1447^^111^1399^81^^^^1
 ;;^UTILITY(U,$J,358.3,28082,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28082,1,2,0)
 ;;=2^J1447
 ;;^UTILITY(U,$J,358.3,28082,1,3,0)
 ;;=3^TBO-FILGRASTIM 1MCG
 ;;^UTILITY(U,$J,358.3,28083,0)
 ;;=J1575^^111^1399^35^^^^1
 ;;^UTILITY(U,$J,358.3,28083,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28083,1,2,0)
 ;;=2^J1575
 ;;^UTILITY(U,$J,358.3,28083,1,3,0)
 ;;=3^IMMUNEGLOBULIN/HYALURONIDASE 100MG
 ;;^UTILITY(U,$J,358.3,28084,0)
 ;;=J1833^^111^1399^41^^^^1
 ;;^UTILITY(U,$J,358.3,28084,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28084,1,2,0)
 ;;=2^J1833
 ;;^UTILITY(U,$J,358.3,28084,1,3,0)
 ;;=3^ISAVUCONAZONIUM 1MG
 ;;^UTILITY(U,$J,358.3,28085,0)
 ;;=J2407^^111^1399^62^^^^1
 ;;^UTILITY(U,$J,358.3,28085,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28085,1,2,0)
 ;;=2^J2407
 ;;^UTILITY(U,$J,358.3,28085,1,3,0)
 ;;=3^ORITAVANCIN 10MG
 ;;^UTILITY(U,$J,358.3,28086,0)
 ;;=J2502^^111^1399^65^^^^1
 ;;^UTILITY(U,$J,358.3,28086,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28086,1,2,0)
 ;;=2^J2502
 ;;^UTILITY(U,$J,358.3,28086,1,3,0)
 ;;=3^PASIREOTIDE LONG ACTING 1MG
 ;;^UTILITY(U,$J,358.3,28087,0)
 ;;=J2547^^111^1399^71^^^^1
 ;;^UTILITY(U,$J,358.3,28087,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28087,1,2,0)
 ;;=2^J2547
 ;;^UTILITY(U,$J,358.3,28087,1,3,0)
 ;;=3^PERAMIVIR 1MG
 ;;^UTILITY(U,$J,358.3,28088,0)
 ;;=J2860^^111^1399^80^^^^1
 ;;^UTILITY(U,$J,358.3,28088,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28088,1,2,0)
 ;;=2^J2860
 ;;^UTILITY(U,$J,358.3,28088,1,3,0)
 ;;=3^SILTUXIMAB 10MG
 ;;^UTILITY(U,$J,358.3,28089,0)
 ;;=J7121^^111^1399^1^^^^1
 ;;^UTILITY(U,$J,358.3,28089,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28089,1,2,0)
 ;;=2^J7121
